Impact of Gaucher disease on COVID-19

Intern Med J. 2020 Jul;50(7):894-895. doi: 10.1111/imj.14894.

Authors

Ari Zimran^{1

2}, Jeff Szer³, Shoshana Revel-Vilk^{1

2}

Affiliations

¹ Gaucher Unit, Shaare Zedek Medical Centre, Jerusalem, Israel.
² Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
³ Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.

No abstract available

Publication types

Letter

MeSH terms

Australia / epidemiology
Betacoronavirus* / isolation & purification
Betacoronavirus* / physiology
COVID-19
Coronavirus Infections* / diagnosis
Coronavirus Infections* / epidemiology
Coronavirus Infections* / immunology
Female
Gaucher Disease* / epidemiology
Gaucher Disease* / immunology
Glycosphingolipids / immunology
Humans
Israel / epidemiology
Male
Middle Aged
Pandemics*
Pneumonia, Viral* / diagnosis
Pneumonia, Viral* / epidemiology
Pneumonia, Viral* / immunology
SARS-CoV-2

Substances

Glycosphingolipids